- Home
- ASM vs TSVT Comparison
ASM vs TSVT Comparison
Compare ASM & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASM
- TSVT
- Stock Information
- Founded
- ASM 1968
- TSVT 2021
- Country
- ASM Canada
- TSVT United States
- Employees
- ASM N/A
- TSVT N/A
- Industry
- ASM Metal Mining
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- ASM Basic Materials
- TSVT Health Care
- Exchange
- ASM Nasdaq
- TSVT Nasdaq
- Market Cap
- ASM 146.2M
- TSVT 128.5M
- IPO Year
- ASM N/A
- TSVT N/A
- Fundamental
- Price
- ASM $1.36
- TSVT $2.61
- Analyst Decision
- ASM Strong Buy
- TSVT Buy
- Analyst Count
- ASM 2
- TSVT 4
- Target Price
- ASM $1.85
- TSVT $8.50
- AVG Volume (30 Days)
- ASM 1.7M
- TSVT 278.0K
- Earning Date
- ASM 03-19-2025
- TSVT 03-04-2025
- Dividend Yield
- ASM N/A
- TSVT N/A
- EPS Growth
- ASM 144.19
- TSVT N/A
- EPS
- ASM 0.02
- TSVT N/A
- Revenue
- ASM $54,326,000.00
- TSVT $45,620,000.00
- Revenue This Year
- ASM $44.87
- TSVT N/A
- Revenue Next Year
- ASM $30.97
- TSVT $37.70
- P/E Ratio
- ASM $54.55
- TSVT N/A
- Revenue Growth
- ASM 18.08
- TSVT N/A
- 52 Week Low
- ASM $0.44
- TSVT $2.29
- 52 Week High
- ASM $1.56
- TSVT $6.00
- Technical
- Relative Strength Index (RSI)
- ASM 55.91
- TSVT 50.02
- Support Level
- ASM $1.35
- TSVT $2.38
- Resistance Level
- ASM $1.51
- TSVT $2.82
- Average True Range (ATR)
- ASM 0.09
- TSVT 0.18
- MACD
- ASM -0.00
- TSVT 0.04
- Stochastic Oscillator
- ASM 52.78
- TSVT 58.18
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.